Efficacy and Safety of Armolipid Plus<sup>®</sup>: An Updated PRISMA Compliant Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
Armolipid Plus<sup>®</sup> is a multi-constituent nutraceutical that claims to improve lipid profiles. The aim of this PRISMA compliant systematic review and meta-analysis was to globally evaluate the efficacy and safety of Armolipid Plus<sup>®</sup> on the basis of the avail...
Main Authors: | Arrigo F. G. Cicero, Cormac Kennedy, Tamara Knežević, Marilisa Bove, Coralie M. G. Georges, Agnė Šatrauskienė, Peter P. Toth, Federica Fogacci |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/13/2/638 |
Similar Items
-
Hypolipaemic nutraceutics: red yeast rice and Armolipid, berberine and bergamot
by: Longina Kłosiewicz-Latoszek, et al.
Published: (2021-03-01) -
Role of Intracellular Na<sup>+</sup> in the Regulation of [Ca<sup>2+</sup>]<sub>i</sub> in the Rat Suprachiasmatic Nucleus Neurons
by: Ruo-Ciao Cheng, et al.
Published: (2019-09-01) -
Comparison of Flow and Compression Properties of Four Lactose-Based Co-Processed Excipients: Cellactose<sup>®</sup> 80, CombiLac<sup>®</sup>, MicroceLac<sup>®</sup> 100, and StarLac<sup>®</sup>
by: Martin Dominik, et al.
Published: (2021-09-01) -
Comparative study of serum Na<sup>+ </sup>and K<sup>+ </sup> levels in senile cataract patients and normal individuals
Published: (2004-08-01) -
Evolution of dyslipidemia: from etiological mechanisms to new targets of personalized preventive nutraceutical therapy with red yeast rice
by: O. Sh. Oinotkinova, et al.
Published: (2019-12-01)